Summary
ELAN has filed a suit against its U.S. partner in the development of MS treatment, Tysabri, over a separate deal the Irish firm has with Johnson & Johnson.
It said it has filed suit against Biogen in Federal Court in New York asking that it find Elan is not in violation of the deal.See the full content of this document
Extract
Elan Files Against U.S. Partner Over Ms Deal [Eire Region]
According to Elan, Bio...
See the full content of this document
Sponsored links
